Von Willebrand factor and cancer: A renewed interest

Thrombosis Research

Volumn 131, Issue 4, 2013, Pages 290-292

  Franchini, Massimo ^a   Frattini, Francesco ^a   Crestani, Silvia ^a   Bonfanti, Carlo ^a   Lippi, Giuseppe ^b  

^a CARLO POMA HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

angiogenesis; cancer; metastasis; von Willebrand disease; von Willebrand factor

Indexed keywords

VON WILLEBRAND FACTOR;

ANGIOGENESIS; BASAL CELL NEVUS SYNDROME; CANCER PATIENT; CELL SURVIVAL; CLINICAL STUDY; COLON CANCER; EXPERIMENTAL STUDY; HUMAN; LEWIS CARCINOMA; MELANOMA CELL; NEOPLASM; PRIORITY JOURNAL; REVIEW;

ANIMALS; BLOOD COAGULATION TESTS; HUMANS; NEOPLASMS; VON WILLEBRAND FACTOR;

EID: 84875737984     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.01.015     Document Type: Review

References (36)

1. M. Franchini, and G. Lippi The role of von Willebrand factor in hemorrhagic and thrombotic disorders Crit Rev Clin Lab Sci 44 2007 115 149
2. M. Franchini, and P.M. von Mannucci Willebrand factor: another Janus-faced hemostasis protein Semin Thromb Hemost 34 2008 663 669
3. Z.M. Ruggeri Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation Best Pract Res Clin Haematol 14 2001 257 279
4. G. Castaman, A.B. Federici, F. Rodeghiero, and P.M. von Mannucci Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment Haematologica 88 2003 94 108
5. M. Franchini, G. Lippi, M. Montagnana, G. Targher, M. Zaffanello, and G.L. Salvagno Hemophilia and cancer: a new challenge for hemophilia centers Cancer Treat Rev 35 2009 374 377
6. F. Langer, A. Amirkhosravi, S.B. Ingersoll, J.M. Walker, B. Spath, and B. Eifrig Experimental metastasis and primary tumor growth in mice with hemophilia A J Thromb Haemost 4 2006 1056 1062
7. L.W. Bruggemann, H.H. Versteeg, T.M. Niers, P.H. Reitsma, and C.A. Spek Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders J Cell Biol Med 12 2008 2622 2627
8. M. Franchini, and P.M. Mannucci Thrombin and cancer: from molecular basis to therapeutic implications Semin Thromb Hemost 38 2012 95 101
9. C.M. Floyd, K. Irani, P.D. Kind, and C.M. von Kessler Willebrand factor interacts with malignant hematopoietic cell lines: evidence for the presence of specific binding sites and modification of von Willebrand factor structure and function J Lab Clin Med 119 1992 467 476
10. M.L. Nierodzik, A. Klepfish, and S. Karpatkin Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo Thromb Haemost 74 1995 282 290
11. V. Terraube, R. Pendu, D. Baruch, M.F. Gebbink, D. Meyer, and P.J. Lenting Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice J Thromb Haemost 4 2006 519 526
12. P. Lenting, C. Casari, O.D. Christophe, and C.V. Denis Von Willebrand factor: the old, the new and the unknown J Thromb Haemost 10 2012 2428 2437
13. R.D. Starke, F. Ferraro, K.E. Paschalaki, N.H. Dryden, T.A. McKinnon, and R.E. Sutton Endothelial von Willebrand factor regulates angiogenesis Blood 117 2011 1071 1080
14. S. Odouard, O.D. Christophe, P.G. de Groot, C.V. Denis, and P.J. Lenting Identification of galectin-1 and galectin-3 as novel partner for von Willebrand factor Arterioscler Thromb Vasc Biol 32 2012 894 901
15. L. Pi, A.K. Shenoy, J. Liu, S. Kim, N. Nelson, and H. Xia CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators FASEB J 26 2012 3365 3379
16. D. van Breevoort, E.L. van Agtmaal, B.S. Dragt, J.K. Gebbinck, I. Dienava-Verdoold, and A. Kragt Proteomic screen identifies IGFBP7 as a novel component of endothelial cell- specific Weibel-Palade bodies J Proteome Res 11 2012 2925 2936
17. M. Le Mercier, S. Fortin, V. Mathieu, R. Kiss, and F. Lefranc Galectins and gliomas Brain Pathol 20 2010 17 27
18. G. Gritti, A. Cortelezzi, P. Bucciarelli, F. Rezzonico, S. Lonati, and S. La Marca Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis Am J Hematol 86 2011 650 656
19. M. Makris Gastrointestinal bleeding in von Willebrand disease Thromb Res 118 Suppl. 1 2006 S13 S17
20. T.E. Warkentin, J.C. Moore, S.S. Anand, E.M. Lonn, and D.G. Morgan Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome Transfus Med Rev 17 2003 272 286
21. J.A. Shavit, and D.G. Motto Coagulation and metastasis - an unexpected role for von Willebrand factor J Thromb Haemost 4 2006 517 518
22. V. Terraube, I. Marx, and C.V. Denis Role of von Willebrand factor in tumor metastasis Thromb Res 120 Suppl. 2 2007 S64 S70
23. S. Mochizuki, K. Soejima, M. Shimoda, H. Abe, A. Sasaki, and H.J. Okano Effects of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor J Natl Cancer Inst 104 2012 906 922
24. S. Karpatkin, E. Pearlstein, C. Ambrogio, and B.S. Coller Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo J Clin Invest 81 1988 1012 1019
25. M. Morganti, A. Carpi, B. Amo-Takyi, A. Sagripanti, A. Nicolini, and R. Giardino von Willebrand's factor mediates the adherence of human tumoral cells to human endothelial cells and ticlopidine interferes with this effect Biomed Pharmacother 54 2000 431 436
26. E.S. Hatzipantelis, M. Athanassiou-Metaxa, N. Gombakis, V. Tzimouli, A. Taparkou, and V. Sidi-Fragandrea Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia Acta Haematol 125 2011 130 135
27. V.S. Schellierer, L. Mueller-Berg, S. Merkel, R. Zimmermann, D.R. Weiss, and A. Schlabrakowski The clinical value of von Wilelbrand factor in colorectal carcinomas Am J Transl Res 3 2011 445 453
28. W.-S. Wang, J.-K. Lin, T.-C. Lin, T.-J. Chiou, J.-H. Liu, and C.-C. Yen Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma World J Gastroenterol 11 2005 2166 2170
29. Z. Zietek, I. Iwan-Zietek, R. Paczulski, M. Kotschy, and Z. von Wolski Willebrand factor antigen in blood plasma of patients with urinary bladder carcinoma Thromb Res 83 1996 399 402
30. A. Gadducci, U. Baicchi, R. Marrai, B. Del Bravo, P.V. Fosella, and V. Facchini Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (VWF) in patients with ovarian carcinoma Gynecol Oncol 53 1993 352 356
31. S.M. Kim, H. Myoung, P.H. Choung, M.J. Kim, S.K. Lee, and J.H. Lee Metastatic leiomyosarcoma in the oral cavity: case report with protein expression profiles J Craniomaxillofac Surg 37 2009 454 460
32. W.G. Jiang, G. Watkins, A. Douglas-Jones, L. Holmgren, and R.E. Mansel Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer BMC Cancer 6 2006 16
33. A. Josefsson, P. Wikstrom, T. Granfors, L. Egevad, L. Karlberg, and P. Stattin Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment Eur Urol 48 2005 577 583
34. M. Franchini Hemophilia and cancer: a personal perspective Blood Transfus 11 2013 26 31
35. L. Gallego, and L. Junquera Association von Willebrand's disease and nevoid basal cell carcinoma syndrome (Gorlin syndrome) Haemophilia 14 2008 835 837
36. J.L. Bercaw, J. Sanchez, R.H. Byrd, M.B. Bhattacharjee, and J.E. Dietrich Sex cord tumor with annular tubules in a young adolescent with von Willebrand's disease J Pediatr Adolesc Gynecol 23 2010 e111 e114